Anzeige
Mehr »
Donnerstag, 17.09.2026 - Börsentäglich über 12.000 News
Heimlicher Börsenstar 2026?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
CL

WKN: A403UF | ISIN: SE0022049920 | Ticker-Symbol: LS60
Frankfurt
17.09.26 | 08:00
0,113 Euro
-3,91 % -0,005
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLINICAL LASERTHERMIA SYSTEMS AB Chart 1 Jahr
5-Tage-Chart
CLINICAL LASERTHERMIA SYSTEMS AB 5-Tage-Chart

Aktuelle News zur CLINICAL LASERTHERMIA SYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.09.Clinical Laserthermia Systems AB announces completion of directed issue2
03.09.Clinical Laserthermia Systems AB resolves on a directed issue2
31.08.Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB announces completion of rights issue of units233NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA...
► Artikel lesen
31.08.Clinical Laserthermia Systems AB: Clinical Laserthermia Systems appoints Katarina Lundqvist as permanent CFO207Lund, Sweden - Clinical Laserthermia Systems AB (publ) (CLS) today announces that Katarina Lundqvist has been appointed permanent Chief Financial Officer (CFO) of CLS, effective 1 September 2026. Katarina...
► Artikel lesen
20.08.Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB announces outcome in rights issue of units146NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA...
► Artikel lesen
18.08.Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB Enters into Top-down Guarantee Agreement in Ongoing Rights Issue of Units202NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA...
► Artikel lesen
13.08.Clinical Laserthermia Systems AB: Last Day of Subscription in Clinical Laserthermia Systems AB' Rights Issue of Units is 18 August 20261
06.08.Clinical Laserthermia Systems AB: Majority of CLS Board and Key Executive Management Commit to Invest in the Company's Rights Issue187Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that a majority of the members of its Board of Directors, together with key members of executive management, have entered...
► Artikel lesen
CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln
04.08.Clinical Laserthermia Systems AB: The Subscription Period in Clinical Laserthermia Systems AB' Rights Issue of Units Begins Today2
29.07.XFRA CAPITAL ADJUSTMENT INFORMATION - 29.07.2026322Das Instrument D7X AU000000DMG9 DRAGON MOUNTAIN GOLD LTD EQUITY wird cum Kapitalmassnahme gehandelt am 29.07.2026 und ex Kapitalmassnahme am 30.07.2026 The instrument D7X AU000000DMG9 DRAGON MOUNTAIN...
► Artikel lesen
23.07.Clinical Laserthermia Systems AB: Board of Directors of Clinical Laserthermia Systems AB resolves on a rights issue of units of initially approximately SEK 39.5 million479NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA...
► Artikel lesen
17.07.Clinical Laserthermia Systems AB: CLS Publishes Half-year Report January - June 2026364Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half-year report for January - June 2026. The report is published earlier than previously communicated...
► Artikel lesen
29.06.Clinical Laserthermia Systems AB: Communique from the Annual General Meeting on Monday June 29th in Clinical Laserthermia Systems AB184Today, June 29th, 2026 the Annual General Meeting (the "AGM") of Clinical Laserthermia Systems AB, 556705-8903, was held. Below is a summary of the decisions taken. All decisions were taken with the...
► Artikel lesen
04.06.Clinical Laserthermia Systems publishes annual report for 20251
28.05.Clinical Laserthermia Systems AB: Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 29, 20262
12.05.Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - March 2026285Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - March 2026.Highlights of First Quarter Interim Report 2026 During the...
► Artikel lesen
28.04.Clinical Laserthermia Systems AB: CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT271Clinical Laserthermia Systems AB (CLS) today announced it has reached an agreement with its strategic partner on an alignment to accelerate the growth of the ClearPoint Prism® business. The plan includes...
► Artikel lesen
20.02.Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2025415Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its Year-end report for January - December 2025.Highlights of the Year-end report 2025The year 2025 represents...
► Artikel lesen
12.12.25Clinical Laserthermia Systems AB: CLS initiates recruitment process for permanent Chief Financial Officer338Clinical Laserthermia Systems AB (publ) ("CLS") today announces that the company has decided to transition from its current interim, part-time consulting CFO arrangement to a permanent and fully employed...
► Artikel lesen
14.11.25Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - September 20251.010Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - September 2025.Highlights of the Third Quarter Interim ReportDuring the...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1